Inventor · disambiguated record
Louis William Licamele
Also filed as: LICAMELE LOUIS · LICAMELE LOUIS WILLIAM
43 granted patents·17 pending applications·280 citations·filing 2008–2025
98Inventor score
Top patents by PatentIndex Score
60 records- 0198US11324735B2Method of treatment with tradipitantVANDA PHARMACEUTICALS INC·Filed 2020·Granted May 10, 2022·7 cites·13 claims
- 0298US11285129B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2021·Granted Mar 29, 2022·8 cites·3 claims
- 0398US10980770B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2020·Granted Apr 20, 2021·7 cites·12 claims
- 0498US8785492B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2013·Granted Jul 22, 2014·41 cites·5 claims
- 0597US12201604B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2024·Granted Jan 21, 2025·1 cites·9 claims
- 0697US11667718B2Cancer treatmentVANDA PHARMACEUTICALS INC·Filed 2021·Granted Jun 6, 2023·3 cites·10 claims
- 0797US10610510B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2018·Granted Apr 7, 2020·9 cites·13 claims
- 0897US9060995B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2014·Granted Jun 23, 2015·22 cites·1 claims
- 0996US10463655B2Method of treatment with tradipitantVANDA PHARMACEUTICALS INC·Filed 2016·Granted Nov 5, 2019·8 cites·7 claims
- 1096US10149829B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2016·Granted Dec 11, 2018·13 cites·14 claims
- 1196US9549913B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2013·Granted Jan 24, 2017·18 cites·14 claims
- 1296US9539234B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2015·Granted Jan 10, 2017·15 cites·5 claims
- 1395US9730910B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2014·Granted Aug 15, 2017·15 cites·5 claims
- 1494US11918556B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2022·Granted Mar 5, 2024·1 cites·3 claims
- 1594US11850229B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2022·Granted Dec 26, 2023·1 cites·3 claims
- 1694US11826339B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2022·Granted Nov 28, 2023·1 cites·4 claims
- 1794US11078289B2Cancer treatmentVANDA PHARMACEUTICALS INC·Filed 2019·Granted Aug 3, 2021·5 cites·9 claims
- 1893US11918557B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2023·Granted Mar 5, 2024·1 cites·10 claims
- 1993US11737993B2Multiple myeloma treatmentVANDA PHARMACEUTICALS INC·Filed 2019·Granted Aug 29, 2023·3 cites·13 claims
- 2093US10449176B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2017·Granted Oct 22, 2019·5 cites·9 claims
- 2192US9855241B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2016·Granted Jan 2, 2018·5 cites·9 claims
- 2291US11833130B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2021·Granted Dec 5, 2023·1 cites·10 claims
- 2391US10772880B2Method of treatment with tradipitantVANDA PHARMACEUTICALS INC·Filed 2019·Granted Sep 15, 2020·6 cites·13 claims
- 2491US10265282B2Cancer treatmentVANDA PHARMACEUTICALS INC·Filed 2018·Granted Apr 23, 2019·6 cites·10 claims
- 2591US9328387B2Antipsychotic treatment based on SNP genotypeLAVEDAN CHRISTIAN·Filed 2008·Granted May 3, 2016·16 cites·12 claims
- 2690US11633377B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2021·Granted Apr 25, 2023·1 cites·11 claims
- 2790US10945988B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2019·Granted Mar 16, 2021·3 cites·13 claims
- 2890US2024342120A1Multiple myeloma treatmentVANDA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2989US9458507B1Antipsychotic treatment based on SNP genotypeVANDA PHARMACEUTICALS INC·Filed 2016·Granted Oct 4, 2016·7 cites·12 claims
- 3089US9080214B2Genetic markers for efficacy of iloperidone in the treatment of psychotic symptomsLAVEDAN CHRISTIAN·Filed 2008·Granted Jul 14, 2015·8 cites·13 claims
- 3186US2023346719A1Multiple myeloma treatmentVANDA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3285US9074254B2Method of predicting a predisposition to QT prolongationLAVEDAN CHRISTIAN·Filed 2008·Granted Jul 7, 2015·6 cites·6 claims
- 3385US8652776B2Prediction of QT prolongation based on SNP genotypeLAVEDAN CHRISTIAN·Filed 2008·Granted Feb 18, 2014·12 cites·8 claims
- 3484US9074255B2Method of predicting a predisposition to QT prolongationLAVEDAN CHRISTIAN·Filed 2010·Granted Jul 7, 2015·6 cites·10 claims
- 3584US9074256B2Method of predicting a predisposition to QT prolongationLAVEDAN CHRISTIAN·Filed 2010·Granted Jul 7, 2015·6 cites·10 claims
- 3684US9072742B2Method of predicting a predisposition to QT prolongationLAVEDAN CHRISTIAN·Filed 2010·Granted Jul 7, 2015·6 cites·10 claims
- 3781US12318375B2Method of treatment with tradipitantVANDA PHARMACEUTICALS INC·Filed 2022·Granted Jun 3, 2025·0 cites·22 claims
- 3881US10563261B2Method of predicting a predisposition to QT prolongationVANDA PHARMACEUTICALS INC·Filed 2017·Granted Feb 18, 2020·2 cites·10 claims
- 3980US11013713B2Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2016·Granted May 25, 2021·1 cites·3 claims
- 4080USRE46604ETreatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2016·Granted Nov 14, 2017·1 cites·8 claims
- 4179US10570453B2Method of predicting a predisposition to QT prolongationVANDA PHARMACEUTICALS INC·Filed 2018·Granted Feb 25, 2020·1 cites·5 claims
- 4279US2025205213A1Method of treatment with tradipitantVANDA PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4379US2025161259A1Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4477US2024350451A1Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4576US10570452B2Method of predicting a predisposition to QT prolongationVANDA PHARMACEUTICALS INC·Filed 2017·Granted Feb 25, 2020·1 cites·10 claims
- 4676US10563260B2Method of predicting a predisposition to QT prolongationVANDA PHARMACEUTICALS INC·Filed 2017·Granted Feb 18, 2020·1 cites·10 claims
- 4773US11090285B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2019·Granted Aug 17, 2021·0 cites·1 claims
- 4870US11458154B2Treatment of CYR61- and VEGF-mediated conditionsVANDA PHARMACEUTICALS INC·Filed 2014·Granted Oct 4, 2022·0 cites·10 claims
- 4970US2022401464A1Treatment of cyr61- and vegf-mediated conditionsVANDA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 5070US2018256521A1Multiple myeloma treatmentVANDA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Louis William Licamele files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →